CSL Limited is a leading Australian multinational biotechnology company specializing in the research, development, manufacturing, and marketing of lifesaving medicines and vaccines. The company’s port... CSL Limited is a leading Australian multinational biotechnology company specializing in the research, development, manufacturing, and marketing of lifesaving medicines and vaccines. The company’s portfolio includes plasma-derived therapies for conditions such as hemophilia and immune deficiencies, influenza vaccines, and treatments for rare and serious diseases. CSL operates globally through its core divisions—CSL Behring, CSL Seqirus, and CSL Vifor—serving patients in over 100 countries. With a history dating back to 1916, CSL has played a pivotal role in advancing public health, including during major global health events like the COVID-19 pandemic. The company is listed on the CHI-X Market Australia – Limit Venue, providing investors access to one of the largest and most innovative biotech firms in the Asia-Pacific region. CSL’s commitment to scientific innovation and global health continues to shape the biotechnology sector and drive advancements in patient care.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for CSL

We have not yet reviewed CSL's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review CSL's data?

Start your 30-day free trial to request a data review for CSL.

Start Free Trial

Legal Center Contact Us